Pediatric Gastroenterology and Hepatology in Italy before and after the COVID-19: Lessons learned and management changes by SIGENP

Valeria Dipasquale; Marco Deganello Saccomani; Angelo Di Giorgio; Salvatore Oliva; Silvia Salvatore; Caterina Strisciuglio; Renato Tambucci; Paolo Lionetti; Claudio Romano

doi:10.1186/s13052-023-01418-7

Pediatric Gastroenterology and Hepatology in Italy before and after the COVID-19: Lessons learned and management changes by SIGENP

Ital J Pediatr. 2023 Jan 26;49(1):15. doi: 10.1186/s13052-023-01418-7.

Authors

Valeria Dipasquale¹, Marco Deganello Saccomani², Angelo Di Giorgio³, Salvatore Oliva⁴, Silvia Salvatore⁵, Caterina Strisciuglio⁶, Renato Tambucci⁷, Paolo Lionetti⁸, Claudio Romano¹

Affiliations

¹ Pediatric Gastroenterology and Cystic Fibrosis Unit, Department of Human Pathology in Adulthood and Childhood "G. Barresi", University of Messina, Messina, Italy.
² Department of Pediatrics, Woman's & Children's University Hospital of Verona, 37126, Verona, Italy. marco.deganello@gmail.com.
³ Pediatric Hepatology, Gastroenterology and Transplantation, Hospital Papa Giovanni XXIII, Bergamo, Italy.
⁴ Pediatric Gastroenterology and Liver Unit, Maternal and Child Health Department, Sapienza University of Rome, Rome, Italy.
⁵ Department of Pediatrics, "F. Del Ponte" Hospital, University of Insubria, Varese, Italy.
⁶ Department of Woman, Child and General and Specialistic Surgery, University of Campania "Vanvitelli", Naples, Italy.
⁷ Digestive Endoscopy Unit, Department of Gastroenterology, Hepatology and Nutrition, Bambino Gesù Children's Hospital, Rome, Italy.
⁸ Department NEUROFARBA, University of Florence, Gastroenterology and Nutrition Unit, Meyer Children's Hospital, Florence, Italy.

Abstract

Around the world, the 2019 Coronavirus disease (COVID-19), caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has raised serious public health problems and major medical challenges. The Italian Society of Pediatric Gastroenterology, Hepatology and Nutrition (SIGENP) published several papers on the impact of COVID-19 on the current management, diagnosis, and treatment of acute and chronic gastrointestinal, hepatic, immune-mediated, and functional disorders. The present article summarizes the most relevant SIGENP reports and consensus during and after the peak of the COVID-19 outbreak, including the diagnosis and treatment of inflammatory bowel disease (IBD), indications and timing of digestive endoscopy, and insights into the novel hepatitis.

Keywords: Anti-TNF-α; COVID-19; Digestive endoscopy; Hepatitis; Inflammatory bowel disease; Liver disease; Pediatrics; SARS-CoV-2; SIGENP; Telemedicine.

Publication types

Review

MeSH terms

COVID-19*
Child
Gastroenterology*
Humans
Inflammatory Bowel Diseases* / therapy
Italy / epidemiology
Liver Diseases* / diagnosis
Liver Diseases* / epidemiology
Liver Diseases* / therapy
SARS-CoV-2